Member Info for BasilAlderman

Yes, it's certainly time to snap up as many GST shares at these prices. People are seriously overlooking the fact that back in 2021 Cake had revenue of $631 Million with an operating income at the time hit $203 million. As a result they experienced a year-on-year increase of 1,800%. If the CAKE team can can replicate even 10% of that sucess under the GST umbrella in 2025 shareholders will be sitting on a goldmine.

0.4 open / 52 week high achieved. That's X10+ this year. Looking forward to the update.

During 2024 you could also look back at PPP and its x 22 gain from 0.525p to 12.20p to get a feel for the kind of gain that is most likely going to happen here next year.

Yes and GST is a company that has just announced a X 9 revenue increase and reduced losses to nearly nothing. A rise to 20p share is now very very doable during 2025. Just look at MOS and ROAD as case studies during 2024. Both are up x 10 and with due respect to both those businesses GST is much further forward.

Yes, Semnet's potential listing on NASDAQ could come any day. DYOR as there's quite a few news items that could be announced.

Yes and just look at what happened at ARB. The big rise happened in 75 days between Dec 2020 and Feb 2021 when the price rose from 10p to over 300p.

2.7p

Google: Open

1.95

High

2.07

2.7p now

Yes, GST will do a X 10 gain during 2025 based on these numbers. Forward looking 20p a share is coming now and that's just for starters. £1 a share in the future is on the horizon.

Yes, I agree. Withdrawing 5 and 6 (details below) sends a strong signal that they are confident of third party funding:

5. That the Directors be generally and unconditionally authorised to exercise all the powers of the Company to allot up to 323,066,667 equity shares in the Company for cash in the respect of unexercised options and warrants over shares in the Company as if Article 3.2 of the Company’s articles of association did not apply to them.

6. That the Directors be and are hereby generally and unconditionally authorised to exercise all the powers of the Company to allot up to 1,950,000,000 equity shares in the Company (representing approximately one-third of the issued share capital).

Yes, surely we must be hearing news from Sareum soon on a number of topics. That was certainly the inference during the last Investor Meet presentation otherwise that last Investor Meet will be viewed as nothing more than SP attempting to pacify shareholders again. Lets see what happens in the coming weeks and hope the granting of these options are for something tangible.

The ARB case study being talked about on here today is really interesting for GST holders. Some of us were lucky to be in ARB when it rocketed and from personal experience if this happened for us here the gain could happen quite rapidly. The big rise over at ARB happened in 75 days between Dec 2020 and Feb 2021 when the price rose from 10p to over 300p. However, the early holders in ARB saw their investment rise X100 from under 3p to over 300p in just 24 months between Feb 2019 and Feb 2021. Like many on here I am prepared to bide my time as GST is the real deal.

Yes, ROAD is a company really going places following its deal with Lidl last month to acquire 12 stores and now this A1 Services news today. 50p+ in 2025 looks a no brainer now.

Yes, that £20 Million MCAP suggestion is peanuts. More like £200 Million for starters in our space, when you read the PWC's dealmaker report on our sector.. It makes for interesting reading. See below for a summary of why PYC is so under valued:

1. Dealmakers in pharmaceuticals and life sciences and in healthcare services are eager to get deals done.

2. Competition for truly innovative assets remains intense.

3. Large pharmaceutical companies will continue to pursue biotech targets and products that can offset revenue declines from lost exclusivity in the coming years.

4. Companies seeking opportunities to digitalise through implementation of analytics technology, digital direct-to-consumer therapeutics offerings, smart health devices and other software innovations will continue to acquire or partner with data and analytics and other technology companies that can deliver these digital solutions.

For example:

5. Merck: Acquired Harpoon Therapeutics for an estimated $680 million

6. Novartis: Acquired Calypso Biotech for $250 million

7. Aditxt: Acquired Evofem Biosciences for $100 million

8. There were 420 M&A deals in our sector globally in Q3 2024, worth a total value of $32.4bn. Source: GlobalData’s Deals Database.

9. The $3.2bn acquisition of Morphic Holdings by Eli Lilly and Co was the industry’s largest disclosed deal in Q3 2024.

10. Interestingly for PYC investors AI / State of the art virtual technology accounted for 11 pharmaceutical deals announced in Q3 2024, worth a total value of $1.7bn. The $1.1bn acquisition of Integrated Oncology Network by Cardinal Health was the industry’s largest disclosed deal.

https://www.pwc.com/gx/en/services/deals/trends/health-industries.html

Yes, warrants to raise £416,667. Another stock of mine, MOS, has been doing this for the last few months and the share price has climbed by x 10. This is a good move by ORCP to bring in finance in the current climate.

Yes, I was one of the lucky one's in SOU back in 2016 to sell at over 70p for a X7. Bought back in September of this year & hoping for another mega rise. 70p again anyone? That would be nice but 10p will be my exit. I expect 10p+ to happen next year.

Yes, GST has acquired Cake and in doing so its cryptocurrency investment platform Bake. Hope this helps. Wake me up at 100p a share!

Cryptonews.com figures for CAKE

Cake had revenue of $631 Million in 2021

Background: Cake Group saw massive growth in 2021 like many decentralized finance (DeFi) platforms. The company released an unaudited financial statement at the time that showed revenue reaching $631 million, year-on-year increase of 1,800%.

Additionally, the Group’s operating income hit $203 million for the year. However, following the massive crash in crypto prices in May 2022, and the prolonged crypto winter, the growth gradually slumped.

Cake Group co-founder Julian Hosp said that the firm’s revenue fell to US$266 million in 2022, and profits dropped to US$23.5 million from US$134 million in 2021.

Yes, I'm with you regarding £1 a share in due course. GST is a "Mega Multi Bagger" in the making.

Yes, looking forward to the financial results especially now that we know that "the Completion payment is expected to be fully settled in cash, funded entirely from the Company's own funds". i.e. very strong messaging that the business is motoring. Bring on those results Tone Goh!